Trials / Completed
CompletedNCT03526302
TroponinT After Subcutaneous Cardioverter-Defibrillator Implantation
Register About Change of hsTROPoninT After Implantation of a Subcutaneous Implantable Cardioverter-Defibrillator
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 43 (actual)
- Sponsor
- Deutsches Herzzentrum Muenchen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Serum Troponin levels pre- and postoperatively will be compared in patients receiving an entirely subcutaneous cardioverter-defibrillator.
Detailed description
To analyze the periprocedural myocardial damage the pre- and postoperative assessment of serum levels of high sensitive TroponinT (hsTnT) is done. The main objectives of the TROPIC register are to evaluate the level of high sensitive TroponinT before and after S-ICD device implantation and to compare these changes in TroponinT-levels with those after standard transvenous ICD-implantation.
Conditions
Timeline
- Start date
- 2018-04-01
- Primary completion
- 2020-09-30
- Completion
- 2020-09-30
- First posted
- 2018-05-16
- Last updated
- 2023-03-20
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03526302. Inclusion in this directory is not an endorsement.